$XBI $67.73 | +0.49%
Table of Contents:
Covid Updates
$
Pipeline Updates
$BIOR +3.1% Biora Therapeutics Shares Data Presented at Digestive Disease Week 2022. source
$JAGX -0.05%Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition. source
$APTO -0.07% Aptose to Provide Program Updates at KOL Webinar on Thursday, June 2nd. source
$PHAT -5.3% Phathom Pharmaceuticals Announces FDA Acceptance for Filing of Vonoprazan NDA for the Treatment of Erosive Esophagitis. source
$KPTI +1.8% The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-031 Study. source
$OBSV 0.0% ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses. source
$VRCA -63.9% Verrica Receives Complete Response Letter from the FDA for its NDA for VP-102 as a Direct Result of Deficiencies at General Reinspection of Sterling Pharmaceuticals Services, LLC. source
Want to get weekly catalyst updates?
*We never spam you - unsubscribe anytime*
Business Updates
$CTXR -4.8% Citius Pharmaceuticals, Inc. Announces Intention to Spinoff Late-Stage Oncology Asset, I/ONTAK, into a New Standalone Publicly Traded Company. source
$RAPT +9.1% RAPT Therapeutics Announces Private Placement Financing of $50 Million. source
$NBIX +4.5% Neurocrine Biosciences Announces Repurchase of Convertible Notes. source
Posted by JM/FS